Resources

Selected
  • SAGE documentation
  • Dengue
Type of publications
Topics
Diseases
Publication date
Available to download in languages
13 results found
2024 ∙ SAGE
Dengue Vaccine (TAK-003) GRADE tables
GRADE table Qdenga Dengue
Download:
2024 ∙ SAGE
Dengue Evidence to Recommendation
Evidence to recommendation table Qdenga Dengue
Download:
2024 ∙ SAGE
WHO position paper on dengue vaccines – May 2024
Position paper Qdenga Dengue
Download:
2023 ∙ SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, September 2023: conclusions and recommendations
Meeting report Dengue Poliomyelitis Smallpox Malaria COVID-19 Mumps Cholera
Download:
2018 ∙ SAGE
What is the efficacy of 3 doses of CYD-TDV in preventing clinical dengue in seronegative individuals 9-16 years of age in the first year following vaccination?
GRADE table Dengue
Download:
2018 ∙ SAGE
What is the efficacy of 3 doses of CYD-TDV in preventing clinical dengue in seropositive individuals 9-16 years of age in the first year following vaccination?
GRADE table Dengue
Download:
2018 ∙ SAGE
Should countries considering introduction of CYD-TDV to reduce the burden of dengue use a pre-vaccination screening or population seroprevalence based criteria?
Evidence to recommendation table Dengue
Download:
2018 ∙ SAGE
Should CYD-TDV be recommended, over no vaccination, to immunocompetent individuals (≥9 years of age) in dengueendemic countries to mitigate the dengue burden of disease?
Evidence to recommendation table Dengue
Download:
2018 ∙ SAGE
What is the duration of protection/risk in seropositive individuals 9-16 years of age vaccinated with CYD-TDV?
GRADE table Dengue
Download:
2018 ∙ SAGE
What is the duration of protection/risk in seronegative individuals 9-16 years of age vaccinated with CYD-TDV?
GRADE table Dengue
Download:
Loading...